Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Feb 2023 for Aspira Women's Health Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -49.0%Entry US$7.80 · Close at T+365 US$3.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert D. Auerbach: trading record in brief
Robert D. Auerbach is a declared insider of Aspira Women's Health Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 23 June 2022 to 9 February 2023, the count stands at 3 filings.
No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants.
Most recently, on 13 February 2023, the filings show a share grant in Aspira Women's Health Inc. The latest purchase dates back some time: it was published 1,512 days ago, on 29 August 2022. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert D. Auerbach
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
38,538 shares0COMMON STOCKSEC:0001745856-23-000001:0
66,667 sharesCommon StockSEC:0001745856-22-000003:0
Canonical exit: 23 Nov 2022 (T+90)
54,825 shares0Common StockSEC:0001745856-22-000002:0
3 of 3 declarations
